WallStreetZenWallStreetZen

AnalystsSubbu Nambi
Subbu Nambi's Stock Forecasts

Analyst Ranking
Top 38%
#1768 out of 4726 analysts
Average Return
+5.05%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good

Subbu Nambi's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Natera IncNTRA
+106.01%$60.27$124.16
2023-12-14 -
2024-11-01
Strong Buy
Castle Biosciences IncCSTL
+60.84%$20.61$33.15
2023-12-14 -
2024-11-01
Strong Buy
Nautilus Biotechnology IncNAUT
+14.47%$2.28$2.61
2024-06-27 -
2024-11-01
Strong Buy
Illumina IncILMN
+13.89%$131.49$149.76
2023-12-14 -
2024-11-01
Strong Buy
Veracyte IncVCYT
+6.32%$32.27$34.31
2024-10-10 -
2024-11-01
Strong Buy

Subbu Nambi Analyst Color

Get additional color on Subbu Nambi's coverage of popular stocks

Subbu Nambi's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Veracyte IncVCYT
1Strong Buy$40.00+16.58%Initiates Coverage On
24 days ago
Guardant Health IncGH
1Strong Buy$36.00+56.52%Upgrades
4 months ago
Sophia Genetics SaSOPH
1Strong Buy$6.00+64.84%Initiates Coverage On
4 months ago
Nautilus Biotechnology IncNAUT
1Strong Buy$6.00+129.89%Initiates Coverage On
4 months ago
Twist Bioscience CorpTWST
1Strong Buy$53.00+27.50%Initiates Coverage On
5 months ago
Castle Biosciences IncCSTL
1Strong Buy$25.00-24.59%Initiates Coverage On
a year ago
Myriad Genetics IncMYGN
1Strong Buy$23.00+27.85%Initiates Coverage On
a year ago
Natera IncNTRA
1Strong Buy$70.00-43.62%Initiates Coverage On
a year ago
Exact Sciences CorpEXAS
1Strong Buy$90.00+28.94%Initiates Coverage On
a year ago
Illumina IncILMN
1Strong Buy$155.00+3.50%Initiates Coverage On
a year ago
10x Genomics IncTXG
1Strong Buy$60.00+267.42%Initiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.